SHIFT AI Newsroom · GLOBAL
Trial Investigates Early Reinitiation of Semaglutide After Sleeve Gastrectomy in Young People
A new trial is exploring the effects of restarting semaglutide early after sleeve gastrectomy surgery in youth, according to a listing on ClinicalTrials.gov.
A trial listed on ClinicalTrials.gov is investigating the early reinitiation of semaglutide after sleeve gastrectomy in youth. The trial aims to explore the effects of restarting semaglutide early after surgery. Semaglutide is a medication used in the management of weight and related conditions. The outcomes of this trial may provide valuable insights into the management of these conditions in young people.
What this means in the UK
This trial may provide insights into the management of weight and related conditions in young people undergoing sleeve gastrectomy, potentially informing future treatment strategies in the UK.
Known facts
- A trial is investigating the early reinitiation of semaglutide after sleeve gastrectomy in youth.